Nutritional implications of glucagon-like peptide receptor agonists
Anti-obesity treatment using incretin-based pharmacotherapy such as glucagon-like peptide receptor agonists (GLP-1 RAs),...
Anti-obesity treatment using incretin-based pharmacotherapy such as glucagon-like peptide receptor agonists (GLP-1 RAs),...
Abstract
BY Dr Giuliana Murfet | Dr. Shanshan Lin |
Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women, in Australia and...
Diabetes is a long-term chronic condition that requires continual clinical input and...
According to the Australian Institute of Health and Welfare (AIHW),in 2021 the incidence of diabetes in Australia increased...
The Diabetes across the Lifecourse: Northern Australia Partnership (the Diabetes Partnership) commenced in the Northern Territory (NT) in 2011. The...
Obesity is a complex condition with genetic, environmental, physiological and behavioural determinants